These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1673486)

  • 1. Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines.
    Lieberman MD; Sigal RK; Williams NN; Daly JM
    J Surg Res; 1991 Apr; 50(4):410-5. PubMed ID: 1673486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
    Chehimi J; Valiante NM; D'Andrea A; Rengaraju M; Rosado Z; Kobayashi M; Perussia B; Wolf SF; Starr SE; Trinchieri G
    Eur J Immunol; 1993 Aug; 23(8):1826-30. PubMed ID: 8102101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
    Chehimi J; Starr SE; Frank I; Rengaraju M; Jackson SJ; Llanes C; Kobayashi M; Perussia B; Young D; Nickbarg E
    J Exp Med; 1992 Mar; 175(3):789-96. PubMed ID: 1346797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
    Robertson MJ; Soiffer RJ; Wolf SF; Manley TJ; Donahue C; Young D; Herrmann SH; Ritz J
    J Exp Med; 1992 Mar; 175(3):779-88. PubMed ID: 1346796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the production of natural killer cell stimulatory factor (NKSF/IL-12) in the ability of B cell lines to stimulate T and NK cell proliferation.
    Valiante NM; Rengaraju M; Trinchieri G
    Cell Immunol; 1992 Nov; 145(1):187-98. PubMed ID: 1358460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
    D'Andrea A; Rengaraju M; Valiante NM; Chehimi J; Kubin M; Aste M; Chan SH; Kobayashi M; Young D; Nickbarg E
    J Exp Med; 1992 Nov; 176(5):1387-98. PubMed ID: 1357073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
    Kobayashi M; Fitz L; Ryan M; Hewick RM; Clark SC; Chan S; Loudon R; Sherman F; Perussia B; Trinchieri G
    J Exp Med; 1989 Sep; 170(3):827-45. PubMed ID: 2504877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells.
    Wolf SF; Temple PA; Kobayashi M; Young D; Dicig M; Lowe L; Dzialo R; Fitz L; Ferenz C; Hewick RM
    J Immunol; 1991 May; 146(9):3074-81. PubMed ID: 1673147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.
    Chan SH; Perussia B; Gupta JW; Kobayashi M; Pospísil M; Young HA; Wolf SF; Young D; Clark SC; Trinchieri G
    J Exp Med; 1991 Apr; 173(4):869-79. PubMed ID: 1672545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
    Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
    Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis.
    Bellone G; Trinchieri G
    J Immunol; 1994 Aug; 153(3):930-7. PubMed ID: 7517976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.
    Liljefors M; Nilsson B; Hjelm Skog AL; Ragnhammar P; Mellstedt H; Frödin JE
    Int J Cancer; 2003 Jul; 105(5):717-23. PubMed ID: 12740924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    Tomescu C; Tebas P; Montaner LJ
    AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction mechanism of human blood CD8+ T cell proliferation and cytotoxicity by natural killer cell stimulatory factor (interleukin-12).
    Nabioullin R; Sone S; Nii A; Haku T; Ogura T
    Jpn J Cancer Res; 1994 Aug; 85(8):853-61. PubMed ID: 7928632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2.
    Chan SH; Kobayashi M; Santoli D; Perussia B; Trinchieri G
    J Immunol; 1992 Jan; 148(1):92-8. PubMed ID: 1345792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation.
    Trinchieri G; Wysocka M; D'Andrea A; Rengaraju M; Aste-Amezaga M; Kubin M; Valiante NM; Chehimi J
    Prog Growth Factor Res; 1992; 4(4):355-68. PubMed ID: 1364096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell stimulatory factor (NKSF)/IL-12 and cytolytic activities of PBL/NK cells from human immunodeficiency virus type-1 infected patients.
    Sirianni MC; Ansotegui IJ; Aiuti F; Wigzell H
    Scand J Immunol; 1994 Jul; 40(1):83-6. PubMed ID: 7913248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
    D'Andrea A; Aste-Amezaga M; Valiante NM; Ma X; Kubin M; Trinchieri G
    J Exp Med; 1993 Sep; 178(3):1041-8. PubMed ID: 8102388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer.
    Jain A; Poonia B; So EC; Vyzasatya R; Burch EE; Olsen HS; Mérigeon EY; Block DS; Zhang X; Schulze DH; Hanna NN; Twadell WS; Yfantis HG; Chan SL; Cai L; Strome SE
    Eur J Cancer; 2013 Oct; 49(15):3344-52. PubMed ID: 23871153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.